https://investorweb.no/ir-channel/SOFTX/event/7debe477-0c76-46e9-b384-3b7ab922f983

The company will provide a market update in connection with the ongoing rights issue.

The focus for the presentation will be to present the new team for shareholders and the upcoming clinical development program for Ventilator Associated Pneumonia (VAP). VAP will be the main focus for SoftOx Solutions AS going forward.

The presentation will be recorded and made available afterwards.

The presenters from the company will be:

1. Ulrik Spork, Incoming Chairman
2. Thomas Bjarnsholt, Incoming CEO
3. Ingrid Juven, CFO

Welcome.
Documents from this event
There’s currently no documents for this event.